|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.60 TWD | +0.13% |
|
-1.32% | +3.61% |
| Capitalization | 22.54B 722M 615M 574M 538M 995M 65.16B 1.08B 6.69B 2.6B 30.78B 2.71B 2.65B 112B | P/E ratio 2025 * |
-82.9x | P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 20.04B 642M 546M 510M 478M 885M 57.91B 963M 5.94B 2.31B 27.35B 2.41B 2.36B 99.67B | EV / Sales 2025 * |
13.5x | EV / Sales 2026 * | - |
| Free-Float |
60.98% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | +0.13% | ||
| 1 week | -1.32% | ||
| Current month | +0.13% | ||
| 1 month | +12.01% | ||
| 3 months | +21.50% | ||
| 6 months | +20.71% | ||
| Current year | +3.61% |
| 1 week | 73.4 |  | 77.5 |
| 1 month | 70.4 | | 84.3 |
| Current year | 52.7 | | 84.3 |
| 1 year | 52.7 | | 84.3 |
| 3 years | 52.7 | | 152 |
| 5 years | 38.5 | | 195 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 2013-03-31 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 2016-05-02 |
Ai Ning Lin
PRN | Corporate Officer/Principal | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 2013-06-13 |
Ming Hsien Chen
BRD | Director/Board Member | - | 2016-09-12 |
Fu Hsiu Yin
BRD | Director/Board Member | - | 2016-09-12 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.13% | -1.32% | -2.61% | -51.56% | 722M | |
| +2.84% | +3.32% | -3.39% | -0.43% | 76.62B | |
| +2.86% | -0.09% | -33.92% | -38.32% | 57.54B | |
| -1.83% | -4.53% | +30.05% | +227.38% | 53.75B | |
| +0.24% | +66.90% | +66.90% | +66.90% | 52.52B | |
| -2.84% | -5.21% | +9.55% | -39.55% | 25.31B | |
| +0.98% | -4.34% | +32.57% | +16.71% | 18.87B | |
| +1.85% | -7.39% | +123.62% | +166.25% | 18.42B | |
| -0.66% | -12.62% | +47.24% | +1,004.75% | 16.49B | |
| -0.04% | -.--% | +57.21% | +154.72% | 14.02B | |
| Average | +0.35% | -2.00% | +32.72% | +150.68% | 33.43B | |
| Weighted average by Cap. | +0.80% | -0.80% | +22.83% | +103.43% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.49B 47.68M 40.57M 37.87M 35.53M 65.7M 4.3B 71.53M 441M 171M 2.03B 179M 175M 7.4B | - |
| Net income | -275M -8.81M -7.5M -7M -6.57M -12.14M -795M -13.22M -81.55M -31.69M -375M -33.07M -32.37M -1.37B | - |
| Net Debt | -2.51B -80.4M -68.4M -63.86M -59.91M -111M -7.25B -121M -744M -289M -3.43B -302M -295M -12.48B | - |
More financial data
* Estimated data
Employees
1,000
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-11 | 74.60 NT$ | +0.13% | 428,986 |
| 25-12-10 | 74.50 NT$ | -1.32% | 858,657 |
| 25-12-09 | 75.50 NT$ | +0.53% | 902,151 |
| 25-12-08 | 75.10 NT$ | -0.27% | 919,215 |
| 25-12-05 | 75.30 NT$ | -0.40% | 546,737 |
End-of-day quote Taiwan S.E., December 10, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
74.60TWD
Average target price
138.00TWD
Spread / Average Target
+84.99%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
